About DNAnexus
DNAnexus operates the Precision Health Data Cloud, a comprehensive platform trusted by hundreds of biomedical organizations worldwide to accelerate scientific discovery and improve patient care. The company provides an enterprise-grade cloud infrastructure that enables pharmaceutical companies, academic medical centers, clinical diagnostics labs, biobanks, and population health programs to manage, analyze, and collaborate on multiomics and multimodal precision health data. The DNAnexus Platform breaks down data silos by creating a single source of truth for genomic, clinical, and other biomedical data types. It offers rapid workflow development with support for multiple bioinformatics languages including Nextflow and WDL, pre-built tools and apps, and seamless integration with existing technology ecosystems including sequencers and R&D applications. The platform features AI and machine learning capabilities for predictive analytics, cohort analysis tools, integrated JupyterLab notebooks, and data visualization applications. DNAnexus serves the entire precision medicine lifecycle from research through clinical diagnostics, with specialized solutions including Innovation Hubs, NGS Data Analysis, Translational Informatics, Population Genomics, and Trusted Regulatory Spaces for regulatory submissions. The company maintains partnerships with major cloud providers and technology partners, and powers large-scale initiatives including the UK Biobank Research Analysis Platform. With regulatory-grade security and compliance certifications, DNAnexus enables organizations to scale on-demand while maintaining data governance and supporting global regulatory collaboration.
Clinical Focus
Medical conditions and clinical areas addressed by DNAnexus.
Who It Serves
Milestones & Awards
Recent Milestones
DNAnexus and Oracle partnership to link genomic data to EHRs; ARPA-H adaptive cancer treatment program; World's largest single-cell dataset available on platform; EpiCypher CUTANA Cloud launch; Accelerated Cure Project for MS Data Challenge Pilot; Longitude Prize Discovery Team selections; Boehringer Ingelheim Prix Galien USA finalist
Awards & Recognition
MedTech Breakthrough's PharmaTech Innovation Award; Frost & Sullivan's 2025 Tech Innovation Award; Prix Galien USA 2025 finalist (with Boehringer Ingelheim); Thomas Laur recognized as Top Healthcare Technology CEO of 2025
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.